An update to the HIV-TRePS system: The development and evaluation of new global and local computational models to predict HIV treatment outcomes, with or without a genotype

Journal of Antimicrobial Chemotherapy

Volumn 71, Issue 10, 2016, Pages 2928-2937

  Revell, Andrew D ^a   Wang, Dechao ^a   Wood, Robin ^b   Morrow, Carl ^b   Tempelman, Hugo ^c   Hamers, Raph L ^d,j   Reiss, Peter ^d,e,i   van Sighem, Ard I ^e,i   Nelson, Mark ^f   Montaner, Julio S G ^g   Lane, H Clifford ^h   Larder, Brendan A ^a   Harrigan, Richard ^g   de Wit, Tobias Rinke ^j   Sigaloff, Kim ^j   Agan, Brian ^k   Marconi, Vincent ^k   Wegner, Scott ^k   Sugiura, Wataru ^l   Zazzi, Maurizio ^m   Kaiser, Rolf ⁿ   Schuelter, Eugen ⁿ   Streinu Cercel, Adrian ^o   Alvarez Uria, Gerardo ^p   Gatell, Jose ^q   Lazzari, Elisa ^q   Gazzard, Brian ^f   Pozniak, Anton ^f   Mandalia, Sundhiya ^f   Webster, Daniel ^r   Smith, Colette ^r   Ruiz, Lidia ^s   Clotet, Bonaventura ^s   Staszewski, Schlomo ^t   Torti, Carlo ^u   Lane, Cliff ^v   Metcalf, Julie ^v   Perez Elias, Maria Jesus ^w   Vella, Stefano ^x   Dettorre, Gabrielle ^x   Carr, Andrew ^y   Norris, Richard ^y   Hesse, Karl ^y   Vlahakis, Emanuel ^z   Barth, Roos ^c   Hoffmann, Chris ^aa,ab   Ene, Luminita ^ac   Dragovic, Gordana ^ad   Diaz, Ricardo ^ae   Sucupira, Cecilia ^ae   Sued, Omar ^af   Cesar, Carina ^af   Madero, Juan Sierra ^ag   Emery, Sean ^ah   Cooper, David ^ah   Baxter, John ^ah   Monno, Laura ^ah   Picchio, Gaston ^ah   deBethune, Marie Pierre ^ah   Khabo, Paul ^ah   Ledwaba, Lotty ^ah   more..

^a HIV Resistance Response Database Initiative (RDI)   (United Kingdom)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c NDLOVU CARE GROUP   (South Africa)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e STICHTING HIV MONITORING   (Netherlands)

^f CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^g BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^h NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

ⁱ ATHENA   (Netherlands)

^j PASER M cohort   (Netherlands)

^k ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^l National Institutes of Health   (Japan)

^m MASTER   (Italy)

ⁿ Arevir Cohort   (Germany)

^o National Institute of Infectious Diseases 'Prof Dr Matei Bals'   (Romania)

^p VFHCS   (India)

^q Department of Neuropathology   (Spain)

^r ROYAL FREE HOSPITAL   (United Kingdom)

^s Fundacion Irsi Caixa   (Spain)

^t UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^u UNIVERSITY OF BRESCIA   (Italy)

^v NATIONAL INSTITUTES OF HEALTH   (United States)

^w INSTITUTO RAMÓN Y CAJAL DE INVESTIGACIÓN SANITARIA IRYCIS   (Spain)

^x SAPIENZA UNIVERSITY OF ROME   (Italy)

^y ST VINCENT S HOSPITAL   (Australia)

^z Taylor's Square Private Clinic   (Australia)

^aa Arum Institute   (South Africa)

^ab JOHNS HOPKINS UNIVERSITY   (United States)

^ac VICTOR BABES NATIONAL INSTITUTE OF PATHOLOGY   (Romania)

^ad UNIVERSITY OF BELGRADE   (Serbia)

^ae FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^af FUNDACIÓN HUÉSPED   (Argentina)

^ag INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^ah NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADULT; ANTIVIRAL THERAPY; ARTICLE; COMPUTATIONAL MODEL; COMPUTER MODEL; FEMALE; GENOTYPE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MODEL; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; TREATMENT RESPONSE; ALGORITHM; COMPUTER SIMULATION; DRUG EFFECTS; EVALUATION STUDY; HEALTH CARE PLANNING; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; SOFTWARE; STATISTICAL MODEL; TREATMENT OUTCOME; VIROLOGY; VIRUS LOAD;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ALGORITHMS; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COMPUTER SIMULATION; GENOTYPE; HEALTH RESOURCES; HIV INFECTIONS; HUMANS; MODELS, STATISTICAL; ROC CURVE; SOFTWARE; SOUTH AFRICA; TREATMENT OUTCOME; VIRAL LOAD;

EID: 84994791060     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkw217     Document Type: Article

References (16)

1. Günthard HF, Aberg JA, Eron JJ et al. Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel. JAMA 2014; 312: 410-25.
2. Writing Group, Williams I, Churchill D et al. British HIVAssociation guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight.). HIV Medicine 2014; 15 Suppl 1: 1-85.
3. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Department of Health and Human Services. http://aidsinfo. nih.gov/contentfiles/lvguidelines/AdultandAdolescentGL.pdf.
4. Degruttola V, Dix L, D'Aquila R et al. The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan. Antivir Ther 2000; 5: 41-8.
5. South African Drug Resistance Guidelines. http://www.sahivsoc.org/upload/documents/HIVDR Strategy.pdf.
6. Gupta RK, Hill A, Sawyer AWet al. Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis. Lancet Infect Dis 2009; 9: 409-17.
7. Larder B, Wang D, Revell A et al. The development of artificial neural networks to predict virological response to combination HIV therapy. Antivir Ther 2007; 12: 15-24.
8. Wang D, Larder B, Revell A et al. A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy. Artif Intell Med 2009; 47: 63-74.
9. Larder BA, Revell A, Mican JM et al. Clinical evaluation of the potential utility of computational modelling as an HIV treatment selection tool by physicians with considerable HIV experience. AIDS Patient Care STDS 2011; 25: 29-36.
10. Revell AD, Wang D, Wood R et al. Computational models can predict response to HIV therapy without a genotype and may reduce treatment failure in different resource-limited settings. J Antimicrob Chemother 2013; 68: 1406-14.
11. Revell AD, Wang D, Wood R et al. An update to the HIV-TRePS system: the development of new computational models that do not require a genotype to predict HIV treatment outcomes. J Antimicrob Chemother 2014; 69: 1104-10.
12. Revell AD, Wang D, Boyd MA et al. The development of an expert system to predict virological response to HIV therapy as part of an online treatment support tool. AIDS 2011; 25: 1855-63.
13. Wensing AM, Calvez V, Huldrych F et al. 2014 Update of the drug resistance mutations in HIV-1. Top Antivir Med 2014; 22: 642-50.
14. Revell AD, Wang D, Harrigan R et al. Modelling response to HIV therapy without a genotype-an argument for viral load monitoring in resource-limited settings. J Antimicrob Chemother 2010; 65: 605-7.
15. WHO. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection. Recommendations for a Public Health Approach. Geneva: WHO, 2013. http://www.who.int/hiv/pub/guidelines/arv2013/download/en/.
16. Stevens WS, Scott LE, Crowe SM. Quantifying HIV for monitoring antiretroviral therapy in resource-poor settings. J Infect Dis 2010; 201 Suppl 1: S16-26.